InvestorsHub Logo
Followers 12
Posts 909
Boards Moderated 0
Alias Born 12/30/2004

Re: None

Wednesday, 09/16/2009 2:51:02 PM

Wednesday, September 16, 2009 2:51:02 PM

Post# of 10803
BSPM - can't post on VMC, so I'm posting here.

Joseph Amiel, who runs Amiel Capital Group, apparently posted this comment on a Seeking Alpha article last May. He says the company is for real.

"Biostar is an American company that owns the Chinese pharmaceuticals co. It went public in the U.S. after going through an exhausting registration process with the SEC. I'm an investor in the co., who went over to see the pharmaceutical facilities and meet with the CEO and other top execs three years ago. Only then did I invest. At the time of our meeting, the CEO laid out an ambitious marketing plan to increase revenue and geographic customer reach in China (it does not export), particularly its drug approved by the Chinese government for over-the-counter sale to cure Hepatits B, which is said to afflict some 10% of Chinese. My recollection is that the co. was then bringing in some $5 million in annual revenue. As was pointed out by Mr. Furman, the co. brought in $33 million in revenue in the last fiscal year. Earnings have grown handsomely as well. The co.'s financial statements are rigorously examined by its Chinese-American CFO (with doctorate in accounting from a U.S. educational institution), whom I have met on several occasions. To answer Mr. Furman's question: Biostar is definitely for real.
Joseph Amiel May 15"

http://seekingalpha.com/article/135570-china-biotech-smallcaps-are-they-for-real

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.